High efficacy of rituximab for myasthenia gravis: a comprehensive nationwide study in Austria-Reference-Cited by-同舟云学术

High efficacy of rituximab for myasthenia gravis: a comprehensive nationwide study in Austria

Published:2019-01-16 Issue:3 Volume:266 Page:699-706
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Topakian Raffi,Zimprich Fritz,Iglseder Stephan,Embacher Norbert,Guger Michael,Stieglbauer Karl,Langenscheidt Dieter,Rath Jakob,Quasthoff Stefan,Simschitz Philipp,Wanschitz Julia,Windisch David,Müller Petra,Oel Dierk,Schustereder Günther,Einsiedler Stefan,Eggers Christian,Löscher Wolfgang

Publisher

Springer Science and Business Media LLC

Subject

Clinical Neurology,Neurology

Link

http://link.springer.com/article/10.1007/s00415-019-09191-6/fulltext.html

Reference32 articles.

1. Gilhus NE (2016) Myasthenia gravis. N Engl J Med 375:2570–2581

2. Stieglbauer K, Pichler R, Topakian R (2017) 10-year-outcomes after rituximab for myasthenia gravis: efficacy, safety, costs of inhospital care, and impact on childbearing potential. J Neurol Sci 375:241–244

3. Howard JF Jr, Utsugisawa K, Benatar M et al (2017) Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study. Lancet Neurol 16:976–986

4. Stieglbauer K, Topakian R, Schäffer V et al (2009) Rituximab for myasthenia gravis: three case reports and review of the literature. J Neurol Sci 280:120–122

5. Benveniste O, Hilton-Jones D (2010) The role of rituximab in the treatment of myasthenia gravis. Eur Neurol Rev 5:95–100

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and laboratory remission with rituximab in anti-MuSK-positive myasthenia gravis;Irish Journal of Medical Science (1971 -);2024-08-01

2. The relationship between neuromyelitis optica spectrum disorder and autoimmune diseases;Frontiers in Immunology;2024-06-27

3. Rituximab alone is as effective as associated with steroids on naive patients with generalized myasthenia gravis;Journal of Neurology;2024-06-05

4. Efficacy and safety of tocilizumab in patients with refractory generalized myasthenia gravis;CNS Neuroscience & Therapeutics;2024-06

5. Generalized myasthenia gravis with acetylcholine receptor antibodies: A guidance for treatment;European Journal of Neurology;2024-02-06